Annual Fundamentals Symposium | Individualizing Patient Care in Different Patient Populations
Friday, December 3, 2021
-
You may need to log in to view video on this page.
OVERVIEW:
Epilepsy is not a monomorphic condition, and to achieve optimal patient outcomes, a provider must personalize care to the unique patient they are treating. A patient’s age, etiology for their seizures, and medical comorbidities all influence treatment and diagnostic testing options. In addition, treatment and diagnostic testing options for patients before, during, and after pregnancy need to be considered.
This session focuses on personalizing treatments for various patient populations from the very young to the very old, including pregnant women and those with other specific conditions or disorders.
Learning Objectives:
Following participation in this activity, participants will be able to:
- Describe the differences between treatment of the very young compared to the very old
- Individualize a treatment plan to address care before, during and after pregnancy
- Describe the non-antiepileptic drugs (AEDs) management of individuals with neurocutaneous disorders
- Prepare a treatment plan for individuals with brain tumors
- Recognize how treatment is impacted by metabolic derangements
Program:
Chair: Christopher Skidmore, MD
Introduction | Christopher Skidmore, MD
Seizures and Epilepsy in the Very Young | Renée Shellhaas, MD, MS, FAES
Neurocutaneous Disorders: It's Not Just About Seizures | Elizabeth Thiele, MD, PhD
An Update on Pregnancy: Maximizing Outcomes Before, During, and After | Elizabeth E. Gerard, MD
Should We Treat Seizures Associated with Tumors Differently? | Edward Avila, MD
How do Metabolic Derangements Alter Treatment? | Lindsay Higdon, MD
What Happens as We Age? | Alice Lam, MD, PhD
Panel Discussion | All Faculty
Education Credit:
2.5 Nursing Contact Hours
2.5 Pharmacy Contact Hours
2.5 CME
This educational activity is supported in part by education grants from: Eisai Inc., Neurelis, Inc., and UCB, Inc.